Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium.

Horm Metab Res 2008 Mar;40(3):210-3

Division of Endocrinology, University of Duisburg-Essen, Essen, Germany.

Twenty-two patients (mean age 61) with metastasizing, progressive, nonradioiodine-accumulating thyroid carcinoma of the follicular epithelium were treated with doxorubicin between 2000 and 2005. Tumors were histologically classified as follicular in 15 patients (68%) and papillary in 7 patients (32%). In addition, nine patients (mean age 51 years) with medullary thyroid carcinoma were treated with doxorubicin between 1997 and 2005. Treatment consisted of doxorubicin: either 8 cycles of 15 mg/m2 weekly or 3 cycles of 60 mg/m2 every 3 weeks, repeated once, depending on response and side effects. The effect of therapy was evaluated by radiographic imaging, [18F] FDG-PET, and bone scans. In patients with papillary or follicular thyroid carcinoma, 5% had a partial regression over 6 months, 42% had stable disease for a median of 7 months (range: 1-22), and 53% had continuous progression established over 5 months (range: 1-11). Three patients died before completing chemotherapy. In patients with medullary thyroid carcinoma, 11% had a partial regression over 6 months followed by stable disease for 3 months, 11% had stable disease over 7 months, and 79% demonstrated progressive disease established over 5 months (range: 2-12). Doxorubicin can be a valid chemotherapy option, especially for advanced or metastatic thyroid carcinoma of the follicular epithelium.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1046781DOI Listing
March 2008

Publication Analysis

Top Keywords

thyroid carcinoma
24
stable disease
12
carcinoma follicular
12
medullary thyroid
12
months range
12
follicular epithelium
12
treated doxorubicin
8
partial regression
8
regression months
8
patients age
8
established months
8
cycles mg/m2
8
disease months
8
months
7
patients
7
carcinoma
6
thyroid
6
follicular
5
carcinoma partial
4
disease median
4

Similar Publications